Vardenafil Hydrochloride

盐酸伐地那非

Report date: 2022/05/18 16:16:04
NME

Base Information

Drug NameVardenafil Hydrochloride
Drug Alias Name瓦地拉非盐酸盐Nuviva伐地那非VardenafilumVivanza +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsDepressionDiabetes MellitusReperfusion Injury +[12] 
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaErectile Dysfunction
Original Approved Country/TerritoryEU
Original Approved Date2003/03/04
Country/TerritoryCzechiaBelgiumCanada +[32] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesTanta UniversityBayer AG
Inactive CompaniesTongji UniversityMcguire Research Institute IncCliniques Universitaires Saint-Luc A.S.B.L. +[6] 
Active IndicationsErectile DysfunctionProstatic Hyperplasia
Inactive IndicationsDepressionDiabetes MellitusReperfusion Injury +[10] 

Other Information

ATC CodeG04BE09
Related LinksWikipediaDrugBankKEGG